Shingles activates when the chickenpox virus, which has been lying dormant in your nerve cells since childhood, escapes the control of your immune system and begins replicating again. The virus never actually leaves your body after chickenpox. It retreats into clusters of nerve cells near the spine and brain, where it sits quietly for decades, kept in check by a specific branch of your immune defenses. When those defenses weaken, whether from aging, stress, illness, or medication, the virus wakes up, travels along a nerve fiber to the skin, and produces the painful rash known as shingles.
How the Virus Stays Dormant for Decades
After you recover from chickenpox, the virus migrates from the skin into nerve cell clusters called ganglia, which sit along the spinal cord and at the base of the skull. Inside these neurons, the virus shifts into a quiet state. Its DNA remains in the cell’s nucleus, but it produces almost no proteins and doesn’t make copies of itself. Lab studies show that only about 4 to 5 percent of neurons in an infected cluster actually harbor detectable viral DNA, and even those cells keep the virus nearly silent.
This isn’t a complete shutdown. The virus maintains a trickle of genetic activity, just enough to persist without triggering the immune system’s alarms. Think of it as the virus idling rather than fully off. It stays this way for years or decades, held in place by a combination of the neuron’s own chemical environment and constant immune surveillance from the outside.
The Immune System’s Role in Keeping It Quiet
Your immune system does the heavy lifting in suppressing the virus. Specifically, it’s your T cells, not antibodies, that matter most here. Antibodies can prevent you from catching chickenpox a second time, but T cells are what stop the dormant virus from reactivating. Two types are especially important: CD4 T cells coordinate the immune response, and CD8 T cells directly attack virus-infected cells.
People with low CD4 T cell counts, such as those with advanced HIV, have a significantly higher risk of shingles. But you don’t need a dramatic immune collapse for the virus to slip through. Even a gradual, age-related decline in T cell numbers and function can open the door. As you get older, the T cells stationed in your skin become less effective. They produce fewer of the signaling molecules needed to fight the virus and begin expressing surface markers associated with exhaustion. At the same time, regulatory T cells that dial down immune activity increase in number. The net result is a slow erosion of the specific immune pressure that keeps the virus contained.
Why Age Is the Biggest Risk Factor
Shingles risk climbs steadily after age 50, and it keeps climbing. Some experts estimate that half of all people who live to 85 will experience shingles at some point. This isn’t because of a single event. It’s the cumulative effect of immune aging. Your body produces fewer new T cells, the existing ones become less responsive, and the specialized immune cells living in your skin gradually lose their ability to detect and contain the virus at the nerve endings where it first tries to re-emerge.
This age-related immune decline is the single most common reason shingles activates. It explains why shingles can appear in otherwise healthy older adults who haven’t been sick, aren’t on medications, and haven’t experienced unusual stress.
Medical Conditions That Raise the Risk
Any condition that weakens the immune system can tilt the balance in the virus’s favor. Cancer, particularly blood cancers like lymphoma and leukemia, substantially increases risk because these diseases directly impair the immune cells responsible for viral surveillance. HIV does the same by depleting CD4 T cells.
Diabetes raises shingles risk by about 30 percent compared to the general population. The risk is even higher for people with poorly controlled blood sugar, those over 65, and those who are obese. Poor glycemic control appears to impair immune function enough to give the virus an opening.
Autoimmune and inflammatory conditions such as lupus and rheumatoid arthritis carry a dual risk: the disease itself can dysregulate immune function, and the medications used to treat it often suppress the immune system further.
Medications That Suppress Immune Defenses
Several categories of drugs lower your body’s ability to keep the virus dormant. Chemotherapy and radiation therapy for cancer are among the most significant. Drugs used after organ transplants or bone marrow transplants deliberately suppress the immune system to prevent rejection, which creates a window of vulnerability. The CDC specifically recommends shingles vaccination before transplantation when possible, because the risk is so elevated afterward.
Biologic therapies used for autoimmune diseases, including drugs that target B cells, also increase risk. Long-term use of corticosteroids, commonly prescribed for conditions like asthma, inflammatory bowel disease, and arthritis, can suppress T cell function enough to trigger reactivation. The risk generally scales with dose and duration.
Stress, Sleep Loss, and the Cortisol Connection
Chronic stress is a plausible trigger, though the evidence is more nuanced than popular wisdom suggests. When you’re under sustained stress, your body’s stress response system floods the bloodstream with cortisol and other hormones that suppress immune cell activity. A large study using data from Korea’s national health panel found that people reporting severe self-rated stress had roughly 48 percent higher odds of developing shingles compared to those with low stress levels.
The research on specific life events like the death of a spouse or a major health crisis is less clear-cut. Some studies find an association, others don’t. The inconsistency likely reflects how differently people experience and metabolize stress, and how hard it is to measure stress objectively. What does seem consistent is that prolonged, unrelenting stress, the kind that disrupts sleep and persists for weeks or months, poses a greater risk than a single acute event. Sleep deprivation itself appears to be an independent risk factor, likely because it impairs the same T cell functions that keep the virus in check.
Physical Trauma as a Local Trigger
One of the more surprising triggers is physical injury. A study of Medicare beneficiaries found that shingles patients were 3.4 times more likely than matched controls to have experienced physical trauma in the week before their outbreak. The connection was location-specific: people who developed shingles on the head and face were more than 25 times as likely to have had a head injury in the preceding week.
The leading explanation is that tissue damage and the resulting inflammation at a specific site can disturb the nerve where the virus is hiding, essentially giving it a local cue to reactivate. This has been documented after surgeries, dental procedures, and injuries. The association weakens as the time gap between injury and outbreak increases, suggesting the trigger is acute rather than cumulative.
What Reactivation Feels Like Before the Rash
Shingles typically announces itself with pain, tingling, or burning in a specific strip of skin before any rash appears. This prodromal phase usually lasts a few days, though about 10 percent of people notice pain and rash appearing at the same time. The sensations can be deceptive. Depending on the location, early shingles pain has been mistaken for a heart attack, appendicitis, sciatica, a severe toothache, or even an eye condition. Some people have undergone unnecessary dental work because the nerve pain mimicked a tooth problem.
The pain ranges from mild tingling to intense burning, throbbing, or stabbing. The affected area is often tender to touch. In rare cases, the virus reactivates and causes pain along a nerve without ever producing a visible rash, a condition called zoster sine herpete.
Can Shingles Happen More Than Once?
Yes, though it’s uncommon. The estimated rate of a second episode in people with healthy immune systems falls between 1 and 5 percent, and recurrences typically happen years after the first episode. People with compromised immune systems face higher odds of repeat episodes. Having shingles once does not guarantee lasting protection against another round.
How Vaccination Changes the Equation
The recombinant zoster vaccine (Shingrix) is over 90 percent effective at preventing shingles in adults 50 and older with healthy immune systems. In clinical trials, effectiveness was 97 percent for adults aged 50 to 69 and 91 percent for those 70 and older. Protection remained strong for at least seven years after vaccination in people over 70. For people with weakened immune systems, effectiveness ranged from 68 to 91 percent depending on the underlying condition. The vaccine works by boosting the specific T cell response that keeps the virus dormant, essentially reinforcing the exact defense that weakens with age.